| Product NDC: | 0053-6871 |
| Proprietary Name: | Stimate |
| Non Proprietary Name: | desmopressin acetate |
| Active Ingredient(s): | 1.5 mg/mL & nbsp; desmopressin acetate |
| Administration Route(s): | NASAL |
| Dosage Form(s): | SPRAY, METERED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0053-6871 |
| Labeler Name: | CSL Behring LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020355 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20110916 |
| Package NDC: | 0053-6871-00 |
| Package Description: | 1 BOTTLE, SPRAY in 1 CARTON (0053-6871-00) > 2.5 mL in 1 BOTTLE, SPRAY |
| NDC Code | 0053-6871-00 |
| Proprietary Name | Stimate |
| Package Description | 1 BOTTLE, SPRAY in 1 CARTON (0053-6871-00) > 2.5 mL in 1 BOTTLE, SPRAY |
| Product NDC | 0053-6871 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | desmopressin acetate |
| Dosage Form Name | SPRAY, METERED |
| Route Name | NASAL |
| Start Marketing Date | 20110916 |
| Marketing Category Name | NDA |
| Labeler Name | CSL Behring LLC |
| Substance Name | DESMOPRESSIN ACETATE |
| Strength Number | 1.5 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Factor VIII Activator [EPC],Increased Coagulation Factor VIII Activity [PE],Increased Coagulation Factor VIII Concentration [PE],Vasopressin Analog [EPC],Vasopressins [Chemical/Ingredient] |